Company / Shareholders' Equity
MEDICINOVA INC Shareholders' Equity History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$41.6M
FY2025
5-year range
$41.6M / $83.7M
FY2021-FY2025
Trend
-33.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $70M to $42M over the past 2 years.
Based on SEC 10-K filings.
$42M in FY2025 with a 3-year CAGR of -16.0%.
Declined from $70M to $42M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -16.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -16.0%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 33.3% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.6M | -33.3% |
| FY2024 | $62.4M | -11.2% |
| FY2023 | $70.2M | +0.0% |
| FY2022 | $70.2M | -16.1% |
| FY2021 | $83.7M | +280.2% |
| FY2014 | $22.0M | +47.9% |
| FY2013 | $14.9M | -36.7% |
| FY2012 | $23.5M | +0.0% |
| FY2011 | $23.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026